5/30
09:30 am
cybn
Numinus and Cybin Embark on a Groundbreaking Journey: Pioneering Phase 3 Trials for Major Depressive Disorder [Yahoo! Finance]
Low
Report
Numinus and Cybin Embark on a Groundbreaking Journey: Pioneering Phase 3 Trials for Major Depressive Disorder [Yahoo! Finance]
5/29
07:59 am
cybn
Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024 [Yahoo! Finance]
Low
Report
Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024 [Yahoo! Finance]
5/29
07:30 am
cybn
Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024
Low
Report
Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024
5/23
12:46 pm
cybn
Psychedelics Closer To Commercialization; Compass Far And Away The Leader [Seeking Alpha]
Low
Report
Psychedelics Closer To Commercialization; Compass Far And Away The Leader [Seeking Alpha]
5/16
01:13 pm
cybn
Cybin Inc. (NYSE: CYBN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Medium
Report
Cybin Inc. (NYSE: CYBN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
5/14
07:42 am
cybn
Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase [Yahoo! Finance]
Low
Report
Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase [Yahoo! Finance]
5/14
07:30 am
cybn
Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase
Low
Report
Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase
5/9
04:03 pm
cybn
Investors Warm Up to Psychedelics as FDA Reviews Treatment for PTSD [Yahoo! Finance]
Low
Report
Investors Warm Up to Psychedelics as FDA Reviews Treatment for PTSD [Yahoo! Finance]
5/9
03:59 pm
cybn
Investors Warm Up to Psychedelics as FDA Reviews Treatment for PTSD [BNN Bloomberg (Canada)]
Neutral
Report
Investors Warm Up to Psychedelics as FDA Reviews Treatment for PTSD [BNN Bloomberg (Canada)]
5/7
08:49 am
cybn
Kaya Holdings Awarded Psilocybin Service Center License, Launches The Sacred Mushroom Psychedelic Treatment Facility [Yahoo! Finance]
Low
Report
Kaya Holdings Awarded Psilocybin Service Center License, Launches The Sacred Mushroom Psychedelic Treatment Facility [Yahoo! Finance]
5/7
05:47 am
cybn
Cybin Inc. (OTCMKTS: CYBN) had its "buy" rating re-affirmed by analysts at Bloom Burton.
Low
Report
Cybin Inc. (OTCMKTS: CYBN) had its "buy" rating re-affirmed by analysts at Bloom Burton.
5/6
08:40 am
cybn
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones [Yahoo! Finance]
Low
Report
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones [Yahoo! Finance]
5/6
08:32 am
cybn
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones
Low
Report
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones
4/25
07:30 am
cybn
Cybin to Participate at the 27th Annual Milken Institute Global Conference
Low
Report
Cybin to Participate at the 27th Annual Milken Institute Global Conference
4/18
07:39 am
cybn
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry [Yahoo! Finance]
Low
Report
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry [Yahoo! Finance]
4/18
07:30 am
cybn
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
Low
Report
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
4/17
07:12 am
cybn
Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003 [Yahoo! Finance]
Low
Report
Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003 [Yahoo! Finance]
4/16
07:45 am
cybn
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder [Yahoo! Finance]
Low
Report
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder [Yahoo! Finance]
4/16
07:30 am
cybn
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder
Low
Report
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder
4/10
07:39 am
cybn
Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference [Yahoo! Finance]
Medium
Report
Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference [Yahoo! Finance]
4/10
07:30 am
cybn
Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Medium
Report
Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
4/9
04:05 am
cybn
EVs and the carbon tax plus other letters, April 9: ‘Most Canadians couldn't care less about what powers the vehicles they drive, as long those vehicles have three things' [Globe and Mail, The (Toronto, Canada)]
Low
Report
EVs and the carbon tax plus other letters, April 9: ‘Most Canadians couldn't care less about what powers the vehicles they drive, as long those vehicles have three things' [Globe and Mail, The (Toronto, Canada)]
3/19
11:53 am
cybn
Cybin Announces Closing of the Oversubscribed Private Placement of U.S. $150 Million
Low
Report
Cybin Announces Closing of the Oversubscribed Private Placement of U.S. $150 Million
3/18
12:57 pm
cybn
Cybin (CYBN) Begins Phase II Study on Anxiety Drug, Stock Up [Yahoo! Finance]
Low
Report
Cybin (CYBN) Begins Phase II Study on Anxiety Drug, Stock Up [Yahoo! Finance]
3/18
09:31 am
cybn
Thinking about buying stock in Aquestive Therapeutics, Spruce Biosciences, Vale, Marathon Digital Holdings, or Cybin?
Low
Report
Thinking about buying stock in Aquestive Therapeutics, Spruce Biosciences, Vale, Marathon Digital Holdings, or Cybin?